EndoG Antibody

EndoG Antibody: The fragmentation of nuclear DNA is a hallmark of apoptotic cell death. The activities of caspase and nuclease are involved in the DNA fragmentation. Caspase-activated deoxyribonuclease (CAD), also termed DNA fragmentation factor (DFF40), is one such nuclease, and is capable of inducing DNA fragmentation and chromatin condensation after cleavage by caspase-3 of its inhibitor ICAD/DFF45. Caspase and CAD independent DNA fragmentation also exists. Recent studies demonstrated that another nuclease, endonuclease G (endoG), is specifically activated by apoptotic stimuli and is able to induce nucleosomal fragmentation of DNA independently of caspase and DFF/CAD. EndoG is a mitochondrion-specific nuclease that translocates to the nucleus and cleaves chromatin DNA during apoptosis. The homologue of mammalian EndoG is the first mitochondrial protein identified to be involved in apoptosis in C. elegans. EndooG also cleaves DNA in vitro.

Dodatkowe informacje:

Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.

Specyfikacja/Zawartość:

• Research area: Apoptosis, Cancer
• Host species: Rabbit
• Species reactivity: Human, Mouse, Rat
• Homology: N/A
• Immunogen: Anti-EndoG antibody (3035) was raised against a peptide corresponding to 15 amino acids near the amino terminus of human ENDOG.
• The immunogen is located within amino acids 40-90 of EndoG.
• Tested Applications: E, WB, IHC-P, IF
• Applications: WB: 0.5-2 μ
• g/mL
• IF: 20 μ
• g/mL
• IHC: 2.5-15 μ
• g/mL.
• Antibody validated: Western Blot in human and mouse samples
• Immunofluorescence and Immunohistochemistry in human samples. All other applications and species not yet tested.
• Specificity: N/A
• Positive control 1: Cat. No. 1211 - HepG2 Cell Lysate
• Positive control 2: Cat. No. 1212 - 3T3 Cell Lysate
• Positive control 3: Cat. No. 1307 - Human Pancreas Tissue Lysate
• Positive control 4: Cat. No. 11-101 - Human Pancreas Tissue Slide
• Positive control 5: N/A
• Positive control 6: N/A
• Predicted molecular weight: Predicted: 33kD
• Observed: 33kD
• MW explanation: N/A
• Validation:

  KD validation (Figure 13, 14): Anti-EndoG antibody (3035) specificity was further verified by EndoG specific knockdown. EndoG signal in human cancer cell lines transfected with EndoG siRNAs was disrupted in comparison with that in cells transfected with control siRNAs.

  Localization validation (Figure 7, 8, 10, 11): EndoG translocation was observed in different cell lines and tissues after treatment. From mitochondria to cytoplasm: figure 7 and figure 8. From cytosol to nucleus: figure 10 and figure 11.

• Isoforms: Human EndoG has only one isoform (297aa, 33kD). Mouse EndoG has one isoform (294aa, 32kD) and Rat EndoG also has one isoform (294aa, 32kD). 3035 can detect human, mouse and rat isoform.
• Purification: EndoG Antibody is affinity chromatography purified via peptide column.
• Clonality: Polyclonal
• Clone: N/A
• Isotype: IgG
• Conjugate: Unconjugated
• Physical state: Liquid
• Buffer: EndoG Antibody is supplied in PBS containing 0.02% sodium azide.
• Concentration: 1 mg/mL
• NCBI official symbol: ENDOG
• Accession #: NP_004426
• Protein GI #: 53759134
• NCBI gene ID#: 2021
• NCBI official full name: endonuclease G
• NCBI organism: Homo sapiens
• SWISSPROT #: Q14249

Wysyłka i przechowywanie:

• EndoG antibody can be stored at 4˚
• C for three months and -20˚
• C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Inne:

Optimal dilutions for each application to be determined by the researcher.